PTC Therapeutics (PTCT) PT Raised to $95 at Wells Fargo
Tweet
Share
E-mailGet Alerts PTCT Hot Sheet
Price: $70.09 -2.4%
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Join SI Premium – FREE
Wells Fargo analyst Ben Burnett raised the price target on PTC Therapeutics (NASDAQ: PTCT) to $95.00 (from $86.00) while maintaining a Overweight rating.
You May Also Be Interested In
- PTC Therapeutics to Participate in Upcoming Investor Conferences
- Zhejiang Sanhua Intelligent Controls (002050:CH) PT Lowered to RMB24.20 at Macquarie
- Elastic NV. (ESTC) PT Raised to $107 at Stifel as Sales Revenue Accelerates
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
